Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-15-091072
Filing Date
2015-03-13
Accepted
2015-03-13 15:35:02
Documents
12
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d888999d10k.htm 10-K 795364
2 EX-23.1 d888999dex231.htm EX-23.1 1650
3 EX-31.1 d888999dex311.htm EX-31.1 8821
4 EX-31.2 d888999dex312.htm EX-31.2 9079
5 EX-32.1 d888999dex321.htm EX-32.1 5702
12 GRAPHIC g888999g64i91.jpg GRAPHIC 60070
  Complete submission text file 0001193125-15-091072.txt   7843967

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT hrtx-20141231.xml EX-101.INS 1363218
7 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20141231.xsd EX-101.SCH 45534
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hrtx-20141231_cal.xml EX-101.CAL 36146
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hrtx-20141231_def.xml EX-101.DEF 235405
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20141231_lab.xml EX-101.LAB 333448
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20141231_pre.xml EX-101.PRE 240712
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33221 | Film No.: 15699200
SIC: 2834 Pharmaceutical Preparations